Our Technology
Leadership Team
Investor Relations
About Us
Contact Us
Investor relations
Posts tagged:
Company Announcement
company news
News
ImmVirX enters the clinic with next generation oncolytic virus
Company Announcements
April 6, 2023
ImmVirX enters the clinic with next generation oncolytic virus
Company Announcements
May 19, 2021
by
Dr Malcolm McColl
ImmVirX receives $2.81M R&D tax refund for FY22
Company Announcements
ImmVirX receives $2.81M R&D tax refund for FY22
Company Announcements
May 19, 2021
by
Join Our Mailing List
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Our mission is to improve outcomes for patients with cancers in which immunotherapy treatments have limited effect
About Us
Our Technology
